Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


HAYDEN JEREMY B. Create: Alert

All | News | Filings
Date FiledTypeDescription
03/21/2023 4 HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 4 on Sight Sciences, Inc.
Txns: Granted 45,100 shares @ $0
Granted 57,700 options to buy @ $9.78, valued at $564.3k
01/05/2023 4 HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 4 on Sight Sciences, Inc.
Txns: Granted 12,000 shares @ $0
Paid exercise price by delivering 1,192 shares @ $12.379, valued at $14.8k
02/11/2022 4 HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 4 on Sight Sciences, Inc.
Txns: Granted 12,000 restricted stock units @ $0
Granted 48,200 options to buy @ $17.52, valued at $844.5k
07/14/2021 3 HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 3 on Sight Sciences, Inc.
10/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2019 4 HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns: Disposed/sold 23,601 options to buy @ $42.1, valued at $993.6k
Granted 7,868 options to buy @ $4.71, valued at $37.1k
08/06/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2019 4 HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns: Granted 12,500 shares @ $0
01/02/2019 4 HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns: Granted 216,449 options to buy @ $0.7445, valued at $161.1k
04/23/2018 3 HAYDEN JEREMY B. (General Counsel) has filed a Form 3 on ENDOLOGIX INC /DE/
03/17/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
03/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/15/2016 4 HAYDEN JEREMY B. (General Counsel & VP of BD) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Exercised (in-or-at-the-money) 1,896 rights @ $2.55, valued at $4.8k
Exercised (in-or-at-the-money) 948 warrants @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy